Clinical trials
Completed Cardiotoxicity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 5 |
| Children's Oncology Group | 4 |
| Mayo Clinic | 2 |
| Alexza Pharmaceuticals, Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Connecticut Children's Medical Center | 1 |
| Daniel Rushing | 1 |
| George Washington University | 1 |
| Henry Ford Health System | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 29 |
| Breast Neoplasms | 13 |
| Neoplasms | 8 |
| Lymphoma | 7 |
| Cardiomyopathies | 3 |
| Heart Failure | 3 |
| Breast Neoplasms, Male | 2 |
| Leukemia | 2 |
| Lung Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.